Skip to content
healthcare.dev

Ibandronate Sodium

NDC 55150-191, Ibandronate Sodium, injection, solution, from Eugia US LLC.

Product NDC
55150-191
Status
Listed
Labeler
Eugia US LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205332
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55150-191 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IBANDRONATE SODIUM3 mg/3mL

Pharmacologic classes

Bisphosphonate [EPC]; Diphosphonates [CS]

Package NDCNDC-11Package
55150-191-83551500191831 SYRINGE, GLASS in 1 CARTON (55150-191-83) / 3 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e81f2c5b-bead-48ac-be3e-016cf963d7ed
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=55150-191
  • NADAC price for package 55150019183

    GET /v1/drugs/nadac/55150019183

Use it

Look up 55150-191 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55150-191 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55150-191. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.